Healthcare Competing in the U.S. Contract Research Market

 

INDUSTRY
Brand and Demand

RELEASE DATE
30-Nov-2006
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
N07A-01-00-00-00
SKU
HC01998-NA-MR_07286
Yes
SHARE

Competing in the U.S. Contract Research Market
Published on: 30-Nov-2006 | SKU: HC01998-NA-MR_07286

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements. Additionally, competitive factors across CROs are analyzed with a special focus on leading CROs. An analysis of clinical trial trends and patterns across regions will allow CROs to understand where future growth opportunities may lie and allow them to further penetrate this dynamic and lucrative market.

Introduction

  • Title
  • Disclaimer
  • Certification
  • Table of Contents

Executive Summary

  • Competing in the U.S. CRO Market

Objectives and Methodology

  • Objectives of the Study
  • Methodology

Outsourcing Patterns and Trends

  • Percent of Pharmaceutical and Biotechnology Outsourcing - By Research Area
  • Percent Clinical Development Outsourcing: Current and Future
  • Research and Development Budget
  • Percent R&D Budget Allocated to CRO Expenditures
  • Percent Increase in CRO Budget Next 12-24 Months
  • Percent Share of Phases in CRO Budget - Current and Projected

Motives and Perceived Benefits of Outsourcing

  • Perceived Benefits of Outsourcing

CRO Utilization Satisfaction and Preferences

  • Oncology
  • Central Nervous System (CNS)
  • Cardiovascular
  • Metabolic Diseases
  • Infectious Diseases
  • Respiratory/Allergy
  • Musculoskeletal/Arthritis
  • Full-Service CRO Preferences
  • Niche CRO Preferences
  • Pre-Clinical Phase Preferences
  • Phase I Preferences
  • Phase II/III Preferences
  • Phase IV Preferences

Market Segments and Criteria for CRO Selection

  • Overall Criteria for CRO Selection (Satisfiers)
  • Areas for Improvement: Current Top Sources of Dissatisfaction
  • Derived vs. Stated Importance
  • Derived vs. Stated Importance: Strategic Issues
  • Derived vs. Stated Importance: Secret Issues
  • Derived vs. Stated Importance: Non-Issues
  • Derived vs. Stated Importance: Basic Requirements
  • Market Segments - The 3 Types of CRO Services Users
  • Criteria for CRO Selection by Market Segment
  • Scope and Intensity of Outsourcing by Market Segment
  • Perceived Benefits and Motives for Outsourcing by Market Segment
  • R&D Budget Size by Market Segment
  • CRO Budget Share of the R&D Budget by Market Segment

CRO Preference Metrics

  • The Importance of CRO Performance Metrics

Perceived Attributes of CROs

  • Relative Perceived Strengths of CROs - The Broad Competitive Landscape

An Evaluation of 11 Large CROs

  • Brand Awareness and Preference of 11 Large CROs
  • Brand Awareness of 11 Large CROs
  • Brand Preference of 11 Large CROs
  • Awareness and Conversion to Preference: 11 Large CROs
  • A Note: The Potential Impact of the Acquisition of Charles River's Capabilities by Kendle
  • Service Category vs Price Category Matrix
  • Service Category vs. Price Category Matrix: The Value Frontier
  • Relative Perceived Strengths of 11 Large CROs

Clinical Trial Trends Across Regions

  • Clinical Trials Per Region - Current and Future 2006-2011

Other Technology Requirements: Current and Future

  • Biomarkers Biologics and Biotechnology Needs - Current and Future
  • IT Capabilities Expected from CROs - Current and Future

Purchase Behavior Patterns and Trends

  • Average No. of CROs Invited per Request for Proposal (RFP) - By Phase
  • Share of Outstanding Budget Among Most Utilized CROs
  • Utilization of Data Collection Capabilities in Phase II-IV Trials
  • Status of Pre-Clinical Drug Discovery Outsourcing to CROs
  • Emerging Factors for Future CRO Selection - Next 5 Years

About Frost & Sullivan

  • Frost & Sullivan

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Brand and Demand research

19 May 2016   |   Global   |   Market Research

Analysis of the Global Commercial Satellite Broadband Market

The commercial satellite broadband market is growing at a strong pace, with an anticipated compound annual growth rate (CAGR) of 6.8% from 2015 to 2022. With the continued adoption of Ka-band technology throughout the industry, satellite broadband can now meet or exceed many landline networks in per...

13 May 2016   |   Asia Pacific   |   Market Research

Country Profile – Russia

A country profile is an instant guide to the political, economic, demographic, industrial, and business environment of a market. The report provides a range of quantitative and qualitative information on a variety of national aspects, including geography, economy, education, demography, labour, poli...

12 May 2016   |   Global   |   Market Research

Distributed Energy Resource Management System (DERMS) Market—Profile of Key Companies

Growing number of distributed resources including solar and EV charging stations is expected to present significant economic and technical challenges. Over the next 5 years, distributed energy resource management system (DERMS) is expected to be one of the preferred solutions for managing these dist...

12 May 2016   |   Europe   |   Market Research

European Food Waste Management Services Market

Food waste is a massive issue that has grave environmental and economic repercussions. Approximately 90 million tonnes of food waste is generated annually in Europe, which could increase by 35% if no actions are taken. The European commission and the United Nations have targets to cut the amount of ...

11 May 2016   |   Global   |   Market Research

Oil and Gas CAPEX—Impact on Process Equipment Market, 2016

As a result of Saudi Arabia's decision to keep producing oil to retain its share in the global oil and gas market, the price of oil dropped below $30 for the first time in a decade, seriously impacting the CAPEX. The aim of this private market insight is to analyze the demand-supply gap in the crude...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements. Additionally, competitive factors across CROs are analyzed with a special focus on leading CROs. An analysis of clinical trial trends and patterns across regions will allow CROs to understand where future growth opportunities may lie and allow them to further penetrate this dynamic and lucrative market.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Industries Healthcare
WIP Number N07A-01-00-00-00
Is Prebook No

Competing in the U.S. Contract Research Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01998-NA-MR_07286